BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reddy DS, Sinha A, Kumar A, Saini VK. Drug re-engineering and repurposing: A significant and rapid approach to tuberculosis drug discovery. Arch Pharm (Weinheim) 2022;:e2200214. [PMID: 35841594 DOI: 10.1002/ardp.202200214] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Reddy DS, Sinha A, Kurjogi MM, Shanavaz H, Kumar A. Design, synthesis, molecular docking, and biological evaluation of coumarin-thymidine analogs as potent anti-TB agents. Arch Pharm (Weinheim) 2023;:e2200633. [PMID: 36634969 DOI: 10.1002/ardp.202200633] [Reference Citation Analysis]
2 Akki M, Reddy DS, Katagi KS, Kumar A, Devarajegowda HC, Kumari M S, Babagond V, Joshi SD. Coumarin Hydrazone Oxime Scaffolds as Potent Anti‐tubercular Agents: Synthesis, X‐ray crystal and Molecular Docking Studies. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202203260] [Reference Citation Analysis]
3 Sinha A, Chaudhary R, Reddy DS, Kongot M, Kurjogi MM, Kumar A. ON donor tethered copper (II) and vanadium (V) complexes as efficacious anti-TB and anti-fungal agents with spectroscopic approached HSA interactions. Heliyon 2022;8:e10125. [PMID: 36033266 DOI: 10.1016/j.heliyon.2022.e10125] [Reference Citation Analysis]